{"entity":{"id":"nct04643418","kind":"trial","name":"Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of MPB-1734 in advanced solid tumours, run by MegaPro Biomedical Co. Ltd., now recruiting.","summary":"Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT04643418 by MegaPro Biomedical Co. Ltd., with 81 participants planned, started 2022-03-08 and due to reach its primary completion in 2025-03-31. Interventions recorded: MPB-1734.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04643418","url":"https://clinicaltrials.gov/study/NCT04643418"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04643418","phase":"1/2","setting":"Phase 1/2a Dose-ranging, Safety, Pharmacokinetics, and Preliminary Efficacy Study of MPB-1734 in Patients With Advanced Solid Tumors in Part 1 and With Selected Solid Tumors in Part 2","sponsor":"MegaPro Biomedical Co. Ltd.","enrolled":81,"outcomes":[]},"route":"/trials/nct04643418/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}